CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance
The emergence of new infections in India is a growing concern
The emergence of new infections in India is a growing concern
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
Dr. Vinod Kumar Paul highlighted the huge gap between the demand for and supply of organs
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
New solvent-free micronization technology expanded at the Darmstadt site in Germany
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
The pilot plant is focused on scaling up beverage production and will support applications
Subscribe To Our Newsletter & Stay Updated